NYSE:LLY - Eli Lilly And Co Stock Price, Forecast & News

Eli Lilly And Co trades on the New York Stock Exchange (NYSE) under the ticker symbol "LLY."

Eli Lilly And Co declared a quarterly dividend on Monday, December 16th. Shareholders of record on Friday, February 14th will be paid a dividend of $0.74 per share on Tuesday, March 10th. This represents a $2.96 dividend on an annualized basis and a yield of 2.13%. The ex-dividend date is Thursday, February 13th. This is a boost from Eli Lilly And Co's previous quarterly dividend of $0.65. View Eli Lilly And Co's Dividend History.

Eli Lilly And Co (NYSE:LLY) posted its quarterly earnings data on Wednesday, October, 23rd. The company reported $1.48 earnings per share for the quarter, beating analysts' consensus estimates of $1.43 by $0.05. The company earned $5.48 billion during the quarter, compared to analysts' expectations of $5.50 billion. Eli Lilly And Co had a return on equity of 107.99% and a net margin of 35.10%. The business's revenue for the quarter was up 3.2% compared to the same quarter last year. During the same period in the previous year, the business posted $1.39 earnings per share. View Eli Lilly And Co's Earnings History.

Eli Lilly And Co is scheduled to release their next quarterly earnings announcement on Thursday, January 30th 2020. View Earnings Estimates for Eli Lilly And Co.

Eli Lilly And Co will be holding an earnings conference call on Thursday, January 30th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Eli Lilly And Co updated its FY20 earnings guidance on Tuesday, December, 17th. The company provided earnings per share (EPS) guidance of $6.70-6.80 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $6.57. The company issued revenue guidance of $23.6-24.1 billion, compared to the consensus revenue estimate of $23.46 billion.

13 brokers have issued 12 month target prices for Eli Lilly And Co's stock. Their forecasts range from $117.49 to $165.00. On average, they anticipate Eli Lilly And Co's stock price to reach $136.18 in the next year. This suggests that the stock has a possible downside of 2.1%. View Analyst Price Targets for Eli Lilly And Co.

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Eli Lilly And Co in the last year. There are currently 3 hold ratings and 10 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Eli Lilly And Co.

News headlines about LLY stock have been trending extremely negative on Monday, according to InfoTrie Sentiment. InfoTrie identifies positive and negative press coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Eli Lilly And Co earned a daily sentiment score of -4.5 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an impact on the stock's share price in the immediate future. View News Stories for Eli Lilly And Co.

Eli Lilly And Co saw a increase in short interest during the month of December. As of December 13th, there was short interest totalling 11,580,000 shares, an increase of 9.8% from the November 28th total of 10,550,000 shares. Based on an average daily trading volume, of 3,280,000 shares, the days-to-cover ratio is currently 3.5 days. Currently, 1.4% of the company's stock are sold short. View Eli Lilly And Co's Current Options Chain.

Some companies that are related to Eli Lilly And Co include Johnson & Johnson (JNJ), Merck & Co., Inc. (MRK), Pfizer (PFE), AbbVie (ABBV), Bristol-Myers Squibb (BMY), Zoetis (ZTS), Allergan (AGN), Mylan (MYL), Jazz Pharmaceuticals (JAZZ), Perrigo (PRGO), Horizon Therapeutics (HZNP), The Medicines (MDCO), Nektar Therapeutics (NKTR), Zogenix (ZGNX) and Pacira Biosciences (PCRX).

Based on aggregate information from My MarketBeat watchlists, some companies that other Eli Lilly And Co investors own include Johnson & Johnson (JNJ), Pfizer (PFE), Merck & Co., Inc. (MRK), AT&T (T), Intel (INTC), JPMorgan Chase & Co. (JPM), Verizon Communications (VZ), Bristol-Myers Squibb (BMY), Bank of America (BAC) and Cisco Systems (CSCO).

Eli Lilly And Co's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Lilly Endowment Inc. (11.93%), New York State Teachers Retirement System (0.14%), OLD National Bancorp IN (0.07%), PGGM Investments (0.06%), Strs Ohio (0.05%) and Gateway Investment Advisers LLC (0.05%). Company insiders that own Eli Lilly And Co stock include Aarti S Shah, Alfonso G Zulueta, Anne E White, Christi Shaw, Daniel Skovronsky, David A Ricks, Donald A Zakrowski, Eli & Co Lilly, Enrique A Conterno, Jackson P Tai, Jeffrey N Simmons, Joshua L Smiley, Lilly Endowment Inc, Melissa S Barnes, Michael J Harrington, Myles O'neill, Stephen F Fry and Susan Mahony. View Institutional Ownership Trends for Eli Lilly And Co.

LLY stock was sold by a variety of institutional investors in the last quarter, including Lilly Endowment Inc., Assenagon Asset Management S.A., Commerzbank Aktiengesellschaft FI, DNB Asset Management AS, Meag Munich Ergo Kapitalanlagegesellschaft MBH, Rhenman & Partners Asset Management AB, State of Alaska Department of Revenue and Janney Montgomery Scott LLC. Company insiders that have sold Eli Lilly And Co company stock in the last year include Aarti S Shah, Alfonso G Zulueta, Christi Shaw, Donald A Zakrowski, Enrique A Conterno, Lilly Endowment Inc, Melissa S Barnes, Michael J Harrington, Myles O'neill and Stephen F Fry. View Insider Buying and Selling for Eli Lilly And Co.

LLY stock was bought by a variety of institutional investors in the last quarter, including PGGM Investments, Hexavest Inc., Centre Asset Management LLC, 6 Meridian, United Services Automobile Association, First American Bank, New York State Teachers Retirement System and Candriam Luxembourg S.C.A.. Company insiders that have bought Eli Lilly And Co stock in the last two years include Anne E White, Daniel Skovronsky, David A Ricks, Jackson P Tai and Joshua L Smiley. View Insider Buying and Selling for Eli Lilly And Co.

Shares of LLY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of LLY stock can currently be purchased for approximately $139.07.

Eli Lilly And Co has a market capitalization of $133.53 billion and generates $24.56 billion in revenue each year. The company earns $3.23 billion in net income (profit) each year or $5.55 on an earnings per share basis. Eli Lilly And Co employs 38,680 workers across the globe.View Additional Information About Eli Lilly And Co.

The official website for Eli Lilly And Co is http://www.lilly.com/.

Eli Lilly And Co's mailing address is LILLY CORPORATE CENTER, INDIANAPOLIS IN, 46285. The company can be reached via phone at 317-276-2000 or via email at [email protected]